HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Tanaka Selected Research

TS951

2/2001Effects of 5-HT(4) receptor agonist prokinetic agents on the action potential parameters of isolated rabbit myocardium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Tanaka Research Topics

Disease

88Neoplasms (Cancer)
08/2020 - 01/2000
30Infections
04/2018 - 03/2000
21Rheumatoid Arthritis
01/2018 - 03/2000
15Carcinoma (Carcinomatosis)
08/2020 - 01/2000
15Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2018 - 04/2000
14Inflammation (Inflammations)
08/2018 - 01/2000
13Type 2 Diabetes Mellitus (MODY)
05/2017 - 03/2000
11Neoplasm Metastasis (Metastasis)
11/2017 - 03/2000
10Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 07/2000
9Necrosis
08/2020 - 03/2000
8Body Weight (Weight, Body)
10/2021 - 11/2001
8Hepatocellular Carcinoma (Hepatoma)
11/2017 - 04/2000
7Prostatic Neoplasms (Prostate Cancer)
08/2018 - 06/2000
7Lung Neoplasms (Lung Cancer)
09/2004 - 01/2000
6Gastroesophageal Reflux (GERD)
06/2017 - 02/2000
6Pain (Aches)
11/2014 - 06/2000
6Lymphoma (Lymphomas)
08/2013 - 07/2000
6Colorectal Neoplasms (Colorectal Cancer)
04/2012 - 01/2000
5Arthritis (Polyarthritis)
01/2019 - 01/2012
5Hypersensitivity (Allergy)
08/2017 - 02/2000
5Diabetes Mellitus
05/2017 - 11/2000
5Hematologic Neoplasms (Hematological Malignancy)
04/2016 - 07/2000
5Neurodegenerative Diseases (Neurodegenerative Disease)
10/2013 - 04/2001
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2013 - 04/2000
5Insulin Resistance
12/2011 - 03/2000
5Hemorrhage
01/2010 - 02/2000
5Autoimmune Diseases (Autoimmune Disease)
01/2008 - 04/2000
5Breast Neoplasms (Breast Cancer)
04/2005 - 01/2000
5Hypothermia
02/2003 - 09/2000
5Leukemia
08/2001 - 07/2000
5Aneurysm (Aneurysms)
05/2001 - 08/2000
4Lupus Nephritis
06/2018 - 01/2001
4Hyperglycemia
01/2018 - 11/2001
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 08/2000
4Carcinogenesis
12/2016 - 12/2001
4Thrombocytopenia (Thrombopenia)
04/2014 - 01/2001
4Graft vs Host Disease (Graft-Versus-Host Disease)
08/2012 - 08/2000
4Peptic Esophagitis (Reflux Esophagitis)
02/2010 - 09/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2007 - 04/2000
4T-Cell Leukemia (Leukemia, T Cell)
06/2006 - 08/2000
4Heart Failure
08/2001 - 11/2000
3Osteoarthritis
03/2019 - 07/2006
3Hepatitis C
09/2017 - 01/2000
3Osteosarcoma (Osteogenic Sarcoma)
08/2017 - 08/2000

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2000
14AntigensIBA
03/2018 - 08/2000
14Messenger RNA (mRNA)IBA
08/2014 - 01/2000
14DNA (Deoxyribonucleic Acid)IBA
04/2013 - 01/2000
10CytokinesIBA
12/2016 - 10/2000
10Monoclonal AntibodiesIBA
02/2016 - 01/2000
10Glucose (Dextrose)FDA LinkGeneric
09/2013 - 02/2000
8AntibodiesIBA
09/2017 - 04/2000
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2019 - 06/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 07/2000
7Biomarkers (Surrogate Marker)IBA
04/2014 - 06/2000
7Peptides (Polypeptides)IBA
04/2013 - 04/2000
6Biological ProductsIBA
08/2020 - 04/2000
6Rituximab (Mabthera)FDA Link
04/2018 - 01/2003
6LigandsIBA
01/2017 - 03/2001
6EnzymesIBA
02/2010 - 01/2001
5Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 01/2001
5MicroRNAs (MicroRNA)IBA
11/2017 - 07/2010
5NucleotidesIBA
01/2017 - 01/2000
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007 - 04/2000
4InterferonsIBA
03/2018 - 07/2010
4Estrogens (Estrogen)FDA Link
01/2018 - 01/2000
4Etoposide (VP 16)FDA LinkGeneric
08/2017 - 08/2001
4SteroidsIBA
04/2016 - 01/2000
4Immunoglobulin G (IgG)IBA
02/2016 - 09/2001
4Pharmaceutical PreparationsIBA
08/2015 - 05/2001
4Methotrexate (Mexate)FDA LinkGeneric
02/2012 - 06/2000
4Transcription Factors (Transcription Factor)IBA
03/2010 - 04/2000
4AutoantibodiesIBA
02/2010 - 02/2005
4Matrix Metalloproteinases (MMPs)IBA
01/2009 - 06/2000
4urinastatin (MR 20)IBA
06/2008 - 09/2000
4Insulin (Novolin)FDA Link
11/2001 - 03/2000
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2005
3C-Reactive ProteinIBA
10/2021 - 12/2000
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2018 - 01/2001
3Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2018 - 05/2016
3GenisteinIBA
08/2018 - 03/2014
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2017 - 05/2006
3Immunosuppressive Agents (Immunosuppressants)IBA
09/2017 - 01/2007
3Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2017 - 06/2000
3Blood Glucose (Blood Sugar)IBA
08/2017 - 01/2002

Therapy/Procedure

41Therapeutics
10/2021 - 01/2000
14Drug Therapy (Chemotherapy)
10/2021 - 05/2000
8Transplantation
09/2017 - 02/2001
8Radiotherapy
05/2010 - 01/2000
7Liver Transplantation
09/2017 - 11/2000
7Hematopoietic Stem Cell Transplantation
01/2017 - 09/2002
7Esophagectomy
02/2010 - 07/2000
6Stem Cell Transplantation
08/2017 - 05/2003
6Lymph Node Excision (Lymph Node Dissection)
05/2014 - 07/2000
6Renal Dialysis (Hemodialysis)
01/2014 - 01/2001
6Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2002 - 07/2000
5Surgical Instruments (Clip)
03/2003 - 06/2000
4Cell Transplantation
04/2019 - 08/2013
4Aftercare (After-Treatment)
08/2018 - 02/2000
4General Anesthesia
02/2003 - 10/2000